ASKA Pharmaceutical Holdings Co., Ltd.

Financial

[
  {
    "link": "quarterly",
    "btn_text": "All Quarterly Results",
    "header": "Quarterly Results Snapshot (Consolidated) - Sep'25 - YoY",
    "rhs": [
      {
        "prefix": "Net Sales ",
        "suffix": "YoY Growth in quarter ended Sep 2025 is 9.94% vs 2.52% in Sep 2024",
        "dir": 1
      },
      {
        "prefix": "Consolidated Net Profit ",
        "suffix": "YoY Growth in quarter ended Sep 2025 is -19.35% vs -52.35% in Sep 2024",
        "dir": 1
      }
    ],
    "table": {
      "header": [
        "Sep'25",
        "Sep'24",
        "Change(%)"
      ],
      "body": [
        {
          "field": "Net Sales",
          "val1": "17,612.00",
          "val2": "16,019.00",
          "chgp": "9.94%",
          "chgp_class": "positive"
        },
        {
          "field": "Operating Profit (PBDIT) excl Other Income",
          "val1": "1,943.00",
          "val2": "2,159.00",
          "chgp": "-10.00%",
          "chgp_class": "negative"
        },
        {
          "field": "Interest",
          "val1": "58.00",
          "val2": "11.00",
          "chgp": "427.27%",
          "chgp_class": "negative"
        },
        {
          "field": "Exceptional Items",
          "val1": "0.00",
          "val2": "0.00",
          "chgp": "",
          "chgp_class": "neutral"
        },
        {
          "field": "Consolidate Net Profit",
          "val1": "1,038.00",
          "val2": "1,287.00",
          "chgp": "-19.35%",
          "chgp_class": "negative"
        },
        {
          "field": "Operating Profit Margin (Excl OI)",
          "val1": "66.50%",
          "val2": "99.20%",
          "chgp": "-3.27%",
          "chgp_class": "negative"
        }
      ]
    }
  },
  {
    "link": "annual",
    "btn_text": "All Annual Results",
    "header": "Annual Results Snapshot (Consolidated) - Mar'25",
    "rhs": [
      {
        "prefix": "Net Sales ",
        "suffix": "YoY Growth in year ended Mar 2025 is 2.06% vs 3.94% in Mar 2024",
        "dir": -1
      },
      {
        "prefix": "Consolidated Net Profit ",
        "suffix": "YoY Growth in year ended Mar 2025 is -32.39% vs 78.03% in Mar 2024",
        "dir": -1
      }
    ],
    "table": {
      "header": [
        "Mar'25",
        "Mar'24",
        "Change(%)"
      ],
      "body": [
        {
          "field": "Net Sales",
          "val1": "64,139.00",
          "val2": "62,843.00",
          "chgp": "2.06%",
          "chgp_class": "positive"
        },
        {
          "field": "Operating Profit (PBDIT) excl Other Income",
          "val1": "7,580.00",
          "val2": "9,163.00",
          "chgp": "-17.28%",
          "chgp_class": "negative"
        },
        {
          "field": "Interest",
          "val1": "51.00",
          "val2": "40.00",
          "chgp": "27.50%",
          "chgp_class": "negative"
        },
        {
          "field": "Exceptional Items",
          "val1": "-300.00",
          "val2": "0.00",
          "chgp": "",
          "chgp_class": "neutral"
        },
        {
          "field": "Consolidate Net Profit",
          "val1": "5,101.00",
          "val2": "7,545.00",
          "chgp": "-32.39%",
          "chgp_class": "negative"
        },
        {
          "field": "Operating Profit Margin (Excl OI)",
          "val1": "83.10%",
          "val2": "103.40%",
          "chgp": "-2.03%",
          "chgp_class": "negative"
        }
      ]
    }
  }
]

Quarterly Results Snapshot (Consolidated) - Sep'25 - YoY

Sep'25

Sep'24

Change(%)

Net Sales

17,612.00

16,019.00

9.94%

Operating Profit (PBDIT) excl Other Income

1,943.00

2,159.00

-10.00%

Interest

58.00

11.00

427.27%

Exceptional Items

0.00

0.00

Consolidate Net Profit

1,038.00

1,287.00

-19.35%

Operating Profit Margin (Excl OI)

66.50%

99.20%

-3.27%

USD in Million.

Compare with Peers

Net Sales

YoY Growth in quarter ended Sep 2025 is 9.94% vs 2.52% in Sep 2024

Consolidated Net Profit

YoY Growth in quarter ended Sep 2025 is -19.35% vs -52.35% in Sep 2024

All Quarterly Results

Annual Results Snapshot (Consolidated) - Mar'25

Mar'25

Mar'24

Change(%)

Net Sales

64,139.00

62,843.00

2.06%

Operating Profit (PBDIT) excl Other Income

7,580.00

9,163.00

-17.28%

Interest

51.00

40.00

27.50%

Exceptional Items

-300.00

0.00

Consolidate Net Profit

5,101.00

7,545.00

-32.39%

Operating Profit Margin (Excl OI)

83.10%

103.40%

-2.03%

USD in Million.

Compare with Peers

Net Sales

YoY Growth in year ended Mar 2025 is 2.06% vs 3.94% in Mar 2024

Consolidated Net Profit

YoY Growth in year ended Mar 2025 is -32.39% vs 78.03% in Mar 2024

All Annual Results